PDSS1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.898300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.457000E-01
Normal-vs-Stage2
4.710300E-02
Normal-vs-Stage3
7.349800E-01
Normal-vs-Stage4
9.450000E-01
Stage1-vs-Stage2
4.424000E-01
Stage1-vs-Stage3
2.658800E-01
Stage1-vs-Stage4
3.161600E-01
Stage2-vs-Stage3
3.207400E-01
Stage2-vs-Stage4
5.197200E-01
Stage3-vs-Stage4
7.267200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.376400E-02
Normal-vs-AfricanAmerican
4.449400E-01
Normal-vs-Asian
3.564400E-01
Caucasian-vs-AfricanAmerican
7.966600E-01
Caucasian-vs-Asian
6.122200E-01
AfricanAmerican-vs-Asian
9.021000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.777800E-01
Normal-vs-Female
5.425700E-02
Male-vs-Female
7.914800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.002400E-01
Normal-vs-Age(41-60Yrs)
1.053350E-01
Normal-vs-Age(61-80Yrs)
6.241200E-01
Normal-vs-Age(81-100Yrs)
6.081800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.267800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.154400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.813200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.022000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.884830E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.049220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.005200E-01
Normal-vs-Daily Drinker
6.713800E-01
Normal-vs-Weekly Drinker
2.563200E-01
Normal-vs-Occasional Drinker
8.952400E-01
Normal-vs-Social Drinker
7.389200E-01
Non Drinker-vs-Daily Drinker
9.702000E-01
Non Drinker-vs-Weekly Drinker
5.152400E-01
Non Drinker-vs-Occasional Drinker
5.626600E-01
Non Drinker-vs-Social Drinker
9.231800E-01
Daily Drinker-vs-Weekly Drinker
5.546600E-01
Daily Drinker-vs-Occasional Drinker
5.686600E-01
Daily Drinker-vs-Social Drinker
9.463600E-01
Weekly Drinker-vs-Occasional Drinker
3.533200E-01
Weekly Drinker-vs-Social Drinker
5.467400E-01
Occasional Drinker-vs-Social Drinker
6.734400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.966600E-01
Normal-vs-Grade 2
7.105000E-01
Normal-vs-Grade 3
6.965400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.015200E-01
Grade 1-vs-Grade 3
7.794600E-01
Grade 1-vs-Grade 4
7.966600E-01
Grade 2-vs-Grade 3
9.004400E-01
Grade 2-vs-Grade 4
7.105000E-01
Grade 3-vs-Grade 4
6.965400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.045200E-01
Normal-vs-NonDiabetic
5.757200E-01
Diabetic-vs-NonDiabetic
5.702100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.158200E-01
Normal-vs-NoPancreatitis
6.176000E-01
Pancreatitis-vs-NoPancreatitis
1.994760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.078200E-02
Normal-vs-N1
6.099600E-01
N0-vs-N1
2.261000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.256000E-02
Normal-vs-TP53-NonMutant
2.646000E-02
TP53-Mutant-vs-TP53-NonMutant
9.928200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
